G42 Healthcare’s inactivated COVID-19 Vaccine trials extended internationally as new centre opens in Bahrain

G42 Healthcare’s inactivated COVID-19 Vaccine trials extended internationally as new centre opens in Bahrain

Abu Dhabi-based G42 Healthcare has extended the world's first Phase III trials of an inactivated COVID-19 vaccine to a new centre in Bahrain with the first volunteers being vaccinated in the Kingdom. The new phase of the #4Humanity trials will reinforce the ongoing collaboration between public health bodies in the UAE and Bahrain in combating the impact of the COVID-19 pandemic and increase the number of individuals who will participate in the trials. In total, up to 6,000 volunteers are being sought for the new centre that will be the third in the ongoing trials after those in the UAE at the Abu Dhabi National Exhibition Centre in Abu Dhabi and Al Qarain Health Center in Sharjah. This is an extension of the ongoing 4Humanity program by G42